The EuroHYP-1 trial is a pan-European, open, randomised, phase III clinical trial which will assess the benefit of therapeutic cooling in adult patients with acute ischaemic stroke. In addition to efficacy and safety, the economic impact of therapeutic hypothermia will be also evaluated.
The EuroHYP consortium brings together leading European experts in statistical design and analysis, therapeutic hypothermia, imaging, health economics, ultrasound, biomarkers, and trial execution (implementation and monitoring) as well as European patient and family advocacy groups and Small and Medium-size Enterprises.
European Stroke Organisation Conference 2015 in Glasgow
EuroHYP-1 will be present at the European Stroke Organisation Conference in Glasgow from 17 – 19 April 2015
Come and visit us at stand 25 in the ESOC Exhibition area!
More information on the conference: http://eso.kenes.com/